Variant report
Variant | esv16382 |
---|---|
Chromosome Location | chr17:53545954-53553610 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:53541053..53543358-chr17:53551283..53553190,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576665445 | chr17:53545968-53545969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563918400 | chr17:53546000-53546001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs567785876 | chr17:53546009-53546010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538467443 | chr17:53546013-53546014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192232819 | chr17:53546031-53546032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369011974 | chr17:53546067-53546068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567842897 | chr17:53546079-53546080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34224910 | chr17:53546093-53546094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534733991 | chr17:53546162-53546163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs117177457 | chr17:53546174-53546175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185078803 | chr17:53546185-53546186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113966104 | chr17:53546196-53546197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73318300 | chr17:53546203-53546204 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs190817610 | chr17:53546214-53546215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536814350 | chr17:53546229-53546230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555658975 | chr17:53546231-53546232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs193079195 | chr17:53546339-53546340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185517609 | chr17:53546348-53546349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573899381 | chr17:53546384-53546385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188288728 | chr17:53546465-53546466 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139924118 | chr17:53546467-53546468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373297351 | chr17:53546470-53546471 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369244837 | chr17:53546492-53546493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577672701 | chr17:53546497-53546498 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555507764 | chr17:53546509-53546510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373938727 | chr17:53546567-53546568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563209831 | chr17:53546575-53546576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531162154 | chr17:53546600-53546601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549298374 | chr17:53546605-53546606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114469887 | chr17:53546606-53546607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573487887 | chr17:53546607-53546608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs180752164 | chr17:53546667-53546668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs201984695 | chr17:53546671-53546672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571315404 | chr17:53546686-53546687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538611820 | chr17:53546741-53546742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551073166 | chr17:53546750-53546751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544045115 | chr17:53546764-53546765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562243520 | chr17:53546854-53546855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149936446 | chr17:53546871-53546872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537285330 | chr17:53546875-53546876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11651780 | chr17:53546906-53546907 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs539819060 | chr17:53546907-53546908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144989199 | chr17:53546921-53546922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534917513 | chr17:53546934-53546935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185844416 | chr17:53546947-53546948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374309504 | chr17:53546996-53546997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34773903 | chr17:53547018-53547019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544998904 | chr17:53547076-53547077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557054182 | chr17:53547078-53547079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544948868 | chr17:53547107-53547108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Chordoma | 18071362 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 19602461 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:53544400-53550000 | Weak transcription | Placenta | Placenta |
2 | chr17:53544600-53551800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr17:53546400-53546600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr17:53546600-53549800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr17:53547800-53548200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr17:53549800-53550800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr17:53550000-53550800 | Enhancers | Placenta | Placenta |
8 | chr17:53550400-53550800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr17:53550600-53551200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr17:53550800-53565000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr17:53551000-53551800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr17:53551800-53552000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr17:53551800-53557400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |